Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erenumab safety in stable angina
NCT02575833Phase 2Completed
- Sponsor
- Amgen
- Start
- Nov 2015
- Primary completion
- Jan 2017
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 2 trial of erenumab in migraine, sponsored by Amgen. Started Nov 2015; status: completed.
02
Drugs
erenumab
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02575833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02575833.